The Role of Epstein-Barr Virus Subtypes in Human Immunodeficiency Virus-Associated Lymphoma

References

• Knowles D. M., Chamulak G., Subar M., Pelicci P. G., Dugan M., Burke J. S., Raphael B., Dalla-Favera R. Clinicopathologic, immunophenotypic, and molecular genetic analysis of AIDS-associated lymphoid neoplasia: Clinical and biological implications. Pathology Annual 1988; 23: 33–67
   PubMed Web of Science ®Google Scholar
• Boyle M. J., Swanson C. E., Turner J. J., Thompson I. L., Roberts J., Penny R., Cooper D. A. Definition of two distinct types of AIDS-associated non-Hodgkin's lympho-ma. British Journal of Haematology 1990; 769: 506–12
   Web of Science ®Google Scholar
• Pluda J. M., Yarchoan R., Jaffe E. S., Feuerstein I. M., Solomon D., Steinberg S. M., Wyvill K. M., Raubitschek A., Katz D., Broder S. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term anti-retroviral therapy. Annals of Internal Medicine 1990; 113: 276–82
   PubMed Web of Science ®Google Scholar
• Beral V., Peterman T., Berkelman R., Jaffe H. AIDS-associated non-Hodgkin lymphoma. Lancet 1991; 337: 805–09
   PubMed Web of Science ®Google Scholar
• Gail M. H., Pluda J. M., Rabkin C. S., Biggar R. J., Goedert J. J., Horm J. W., Sondik E. J., Yarchoan R., Broder S. Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. Journal of the National Cancer Institute 1991; 10: 695–701
   Web of Science ®Google Scholar
• Epstein M. A., Achong B. G., Barr Y. M. Virus particles in cultured lymphoblasts from burkitt's lymphoma. Lancet 1964; i: 702–3
   Web of Science ®Google Scholar
• Weiss L. M., Movahed L. A., Warnke R. A., Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. New England Journal of Medicine 1989; 320: 502–06
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I., Herbst H., Neidobitek G., Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive analplastic large cell lymphoma by combined southern blot and in-situ hybridization. Blood 1989; 74: 810–16
   PubMed Web of Science ®Google Scholar
• Penn I. The Occurrence of Malignant Tumors in Immunosuppressed States. Progress in Allergy 1986; 37: 259–300
   PubMedGoogle Scholar
• Penn I. Cancers complicating organ transplantation. New England Journal of Medicine 1990; 323: 1767–69
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S. J., Pallesen G., Franzmann M. B., Karkov J., Black F., Skinhoj P., Pedersen C. AIDS-related lymphoma: Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. American Journal of Pathology 1991; 138: 149–63
   PubMed Web of Science ®Google Scholar
• Uccini S., Monardo F., Ruco L. P., Baroni C. D., Faggioni A., Agliano A. M., Gradilone A., Manzari V., Vago L., Costanzi G., Carbone A., Boiocchi M., De Re V. High frequency of Epstein-Barr virus genome in HIV positive patients with Hodgkin's disease. Lancet 1989; i: 1456
   Google Scholar
• Uccini S., Monardo F., Stoppacciaro A., Gradilone A., Agliano A. M., Faggioni A., Manzari V., Vago L., Costanzi G., Ruco L. P., Baroni C. D. High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients. International Journal of Cancer 1990; 46: 581–85
   PubMed Web of Science ®Google Scholar
• Yarchoan R., Redfield R. R., Broder S. Mechanisms of B Cell Activation in Patients with Acquired Immunodeficiency Syndrome and Related Disorders. Journal of Clinical Investigation 1986; 78: 439–47
   PubMed Web of Science ®Google Scholar
• Klein G. Viral latency and transformation: The strategy of Epstein-Barr virus. Cell 1989; 58: 5–8
   PubMed Web of Science ®Google Scholar
• Sculley T. B., Apolloni A., Stumm R., Moss D. J., Mueller-Lantczh N., Misko I. S., Cooper D. A. Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus. Virology 1989; 171: 401–08
   PubMed Web of Science ®Google Scholar
• Rowe M., Young L. S., Cadwallader K., Petti E., Kieff E., Rickinson A. B. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extend to the EBNA 3 family of nuclear proteins. Journal of Virology 1989; 63: 1031–39
   PubMed Web of Science ®Google Scholar
• Adldinger H. K., Delius H., Freese U. K., Clarke J., Bornkamm G. W. A putative transforming gene of jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 1985; 141: 221–34
   PubMed Web of Science ®Google Scholar
• Hammerschmidt W., Sugden B. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 1989; 340: 393–97
   PubMed Web of Science ®Google Scholar
• Skare J., Farley J., Strominger J. L., Fresen K. O., Cho M. S., zur Hausen H. Transformation by Epstein-Barr virus requires DNA sequences in the region of Bam HI fragments Y and H. Journal of Virology 1985; 55: 286–97
   PubMed Web of Science ®Google Scholar
• Rowe M., Rooney C. M., Rickinson A. B., Lenoir G. M., Rupani H., Moss D. J., Stein H., Epstein M. A. Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma. International Journal of Cancer 1985; 35: 435–41
   PubMed Web of Science ®Google Scholar
• Dambaugh T., Hennessy K., Fennewald S., Kieff E. The virus genome and its expression in latent infection. Epstein-Barr virus: Recent Advances, M. A. Epstein, B. G. Achong. Heinemann Medical Books, London 1986; 14–45
   Google Scholar
• Moss D. J., Misko I. S., Burrows S. R., Burman K., McCarthy R., Sculley T. B. Cytotoxic T-Cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Nature 1988; 331: 719–21
   PubMed Web of Science ®Google Scholar
• Moss D. J., Misko I. S., Sculley T. B., Apolloni A., Khanna R., Burrows S. R. Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen A proteins as a target for EB-specific T cell lysis. Seminars in Immunpathology 1991; 13: 147–56
   PubMed Web of Science ®Google Scholar
• Rickinson A. B., Young L. S., Rowe M. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus transformed B cells. Journal of Virology 1987; 61: 1310–17
   PubMed Web of Science ®Google Scholar
• Gledhill S., Gallagher A., Jone D. B., Krajewski A. S., Alexander F. E., Klee E., Wright D. H., O'Brien C. O., Onions D. E., Jarrett R. F. Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples. British Journal of Cancer 1991; 64: 227–32
   PubMed Web of Science ®Google Scholar
• Boyle M. J., Sewell W. A., Sculley T., Apolloni A., Turner J. J., Swanson C. E., Penny R., Cooper D. A. Subtypes of Epstein-Barr virus in HIV-associated non-Hodgkin lymphoma. Blood 1991; 78: 3001–3011
   Google Scholar
• Goldschmidts W., Bhatia M., Gutierrez K., Carolan M., Akar N., Magrath I. Epstein-Barr virus genotypes in AIDS associated lymphomas are similar to those in endemic Burkitt lymphomas. Proceedings of the American Association for Cancer Research 1991; 32: 222, (abtr No. 1320)
   Google Scholar
• Kyaw M. T., Hurren L., Evans L., Moss D. J., Cooper D. A., Benson E., Esmore D. Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Research. 1992, in press
   Google Scholar
• Sixbey J. W., Chesney P. J., Shirley P., Buntin D. M., Resnick L. Detection of a second widespread strain of Epstein-Barr virus. Lancet 1989; ii: 761–65
   Google Scholar
• Gilligan K., Rajadurai P., Resnick L., Raab-Traub N. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proceedings of the National Academy of Sciences USA 1990; 87: 8790–94
   PubMed Web of Science ®Google Scholar
• Boyle M. J., Vasak E., Tschuchnigg M., Turner J. J., Sculley T., Penny R., Cooper D. A., Tindall B., Sewell W. A. Subtypes of Epstein-Barr virus (EBV) in Hodgkin's Disease: Association between B-type EBV and immunodeficiency. Blood 1993, In press
   Web of Science ®Google Scholar
• Boyle M. J., Sculley T. B., Cooper D. A., Turner J. J., Penny R., Sewell W. A. Epstein-Barr Virus and Human Immunodeficiency Virus play no direct role in the Persistent Generalised Lymphadenopathy Syndrome. Clinical and Experimental Immunology 1992; 87: 357–361
   PubMedGoogle Scholar
• Chappuis B. B., Muller H., Stutte J., Hey M. M., Hubner K., Muller-Hermelink H. K. Identification of EBV-DNA in lymph nodes from patients with lymphadenopathy and lymphomas associated with AIDS. Virchows Archives 1990; 58: 199–205
   Web of Science ®Google Scholar
• Uccini S., Monardo F., Vitolo D., Faggioni A., Gradilone A., Agliano A. M., Manzari V., Ruco L. P., Baroni C. D. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) antigens and genome in lymph nodes of HIV-positive patients affected by persistent generalised lymphadenopathy (PGL). American Journal of Clinical Pathology 1989; 92: 729–35
   PubMed Web of Science ®Google Scholar
• Chappuis B. B., Muller-Hermelink H. K. EBV-DNA in lymphoid tissue. American Journal of Clinical Pathology 1989; 92: 255–56
   PubMed Web of Science ®Google Scholar
• Chappuis B. B., Nezelof C., Muller H., Muller-Hermelink H. K. Different Epstein-Barr virus expression in lymphomas from immunocompromised and immuncompetent patients. American Journal of Pathology 1990; 136: 751–57
   PubMed Web of Science ®Google Scholar
• Amadori A., Chieco-Bianchi L. B cell activation and HIV-1 infection: deeds and misdeeds. Immunology Today 1990; 11: 374–78
   PubMedGoogle Scholar
• Andersson J., Ernberg I. Management of Epstein-Barr virus infections. American Journal of Medicine 1988; 85(supp2A)107–15
   PubMedGoogle Scholar
• Cleary M. L., Dorfman R. F., Sklar J. Failure in immunological control of the virus infection: Post-transplant lymphomas. The Epstein-Barr virus: Recent Advances., M. A. Epstein, B. G. Achong. Heinemann Medical Books, London 1986
   Google Scholar
• Shibata D., Weiss L. M., Nathwani B. N., Brynes R. K., Levine A. M. Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 1991; 77: 1527–43
   PubMed Web of Science ®Google Scholar
• Neri A., Barriga F., Inghirami G., Knowles D. M., Neequaye J., Magrath I. T., Dalla-Favera R. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 1991; 77: 1092–95
   PubMed Web of Science ®Google Scholar
• Cheah M. S. C., Ley T. J., Tronick S. R., Robbins K. C. fgr proto-oncogene mRNA induced in B Lymphocytes by Epstein-Barr virus infection. Nature 1986; 319: 238–40
   PubMed Web of Science ®Google Scholar
• Diamond A., Cooper G. M., Ritz J., Lane M. Identification and molecular cloning of the human B-lym transforming gene activated in Burkitt's lymphomas. Nature 1983; 305: 112–15
   PubMed Web of Science ®Google Scholar
• Subar M., Neri A., Inghirami G., Knowles D. M., Dalla-Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988; 72: 667–71
   PubMed Web of Science ®Google Scholar
• Emilie D., Peuchmaur M., Maillot M. C., Crevon M. C., Brousse N., Delfraissy J. F., Dormont J., Galanaud P. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. Journal of Clinical Investigation 1990; 86: 148–59
   PubMed Web of Science ®Google Scholar
• Boyle M. J., Berger M. F., Tschuchnigg M., Valentine J. E., Cooper D. A., Turner J. J., Penny R., Sewell W. A. Increased expression of gamma-interferon in hyperplastic lymph nodes from HIV-infected patients. Clinical and Experimental Immunology 1993, in press
   PubMed Web of Science ®Google Scholar
• Pallesen G., Gerstoft J., Mathiesen L. Stages in LAV/HTLV-3 lymphadenitis 1. Histological and immunological classification. Scandinavian Journal of Immunology 1987; 25: 83–91
   PubMed Web of Science ®Google Scholar
• Said J. W. Pathology of AIDS and HIV infection. Major Problems in Pathology, G. Nash, J. W. Said. W. B. Saunders, Philadelphia 1992; 26: 35–59
   Google Scholar
• Scala G., Morrone G., Tamburrini M., Alfinito F., Pastore C. I., D'Alessio G., Venuta S. Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line. Journal of Immunology 1987; 138: 2527–34
   PubMed Web of Science ®Google Scholar
• Yokoi T., Miyawaki T., Yachie A., Kato K., Kasahara Y., Taniguchi N. Epstein-Barr virus-immortalised B cells produce IL-6 as an autocrine growth factor. Immunology 1990; 70: 100–105
   PubMed Web of Science ®Google Scholar
• Scala G., Quinto I., Ruocco M. R., Arcucci A., Mallardo M., Caretto P., Forni G., Venuta S. Expression of an exogenous interleukin 6 gene in human Epstein Barr Virus B cells confers growth advantage and in vivo tumorigenicity. Journal of Experimental Medicine 1990; 172: 61–68
   PubMed Web of Science ®Google Scholar
• Gregory C. D., Dive C., Henderson S., Smith C. A., Williams G. T., Gordon J., Rickinson A. B. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991; 349: 612–14
   PubMed Web of Science ®Google Scholar
• Karp J. E., Broder S. Acquired immunodeficiency syndrome and non-Hodgkin's lymphomas. Cancer Research 1991; 51: 4743–56
   PubMed Web of Science ®Google Scholar
• McDonnell T. J., Korsmeyer S. J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 1991; 349: 254–56
   PubMed Web of Science ®Google Scholar
• Pallesen G., Hamilton-Dutoit S. J., Rowe M., Lisse I., Ralfkiaer E., Sandvej K., Young L. S. Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells. Journal of Pathology 1991; 165: 289–99
   PubMed Web of Science ®Google Scholar
• Torbett B. E., Picchio G., Mosier D. E. Hu-PBL-SCID mice: A model for human immune function, AIDS, and lymphomagenesis. Immunology Reviews 1991; 124: 139–64
   PubMed Web of Science ®Google Scholar
• Pallesen G., Hamilton-Dutoit S. J., Rowe M., Young L. S. Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 1991; 337: 320–22
   PubMed Web of Science ®Google Scholar
• Pallesen G., Sandvej K., Hamilton-Dutoit S. J., Rowe M., Young L. S. Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells. Blood 1991; 78: 1162–65
   PubMed Web of Science ®Google Scholar
• Defrance T., Vanbervliet B., Briere F., Durand I., Rousset F., Banchereau J. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. Journal of Experimental Medicine 1992; 175: 671–82
   PubMed Web of Science ®Google Scholar
• Hsu D. H., Malefyt R. D. W., Fiorentino D. F., Dang M. N., Vierera P., DeVries J., Spits H., Mosmann T. R., Moore K. W. Expression of Interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 1990; 250: 830–32
   PubMed Web of Science ®Google Scholar
• Baichwal V. R., Hammerschmidt W., Sugden B. Characterization of the BNLF-1 oncogene of Epstein-Barr virus. Current Topics in Microbiology and Immunology 1989; 144: 233–39
   PubMed Web of Science ®Google Scholar
• Dawson C. W., Rickinson A. B., Young L. S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990; 334: 777–80
   Web of Science ®Google Scholar
• Fahraeus R., Rymo L., Rhim J. S., Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 1990; 345: 447–49
   PubMed Web of Science ®Google Scholar